Thomas F. Isett
2021
In 2021, Thomas F. Isett earned a total compensation of $4.8M as Executive Chairman, President and Chief Executive Officer at iBio, a 171% increase compared to previous year.
Compensation breakdown
| Bonus | $759,500 |
|---|---|
| Option Awards | $3,539,622 |
| Salary | $526,090 |
| Other | $14,500 |
| Total | $4,839,712 |
Isett received $3.5M in option awards, accounting for 73% of the total pay in 2021.
Isett also received $759.5K in bonus, $526.1K in salary and $14.5K in other compensation.
Rankings
In 2021, Thomas F. Isett's compensation ranked 2,728th out of 12,405 executives tracked by ExecPay. In other words, Isett earned more than 78.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,728 out of 12,405 | 78th |
Division Manufacturing | 1,078 out of 5,494 | 80th |
Major group Chemicals And Allied Products | 424 out of 2,369 | 82nd |
Industry group Drugs | 370 out of 2,090 | 82nd |
Industry Pharmaceutical Preparations | 246 out of 1,537 | 84th |
Source: SEC filing on October 26, 2021.
Isett's colleagues
We found two more compensation records of executives who worked with Thomas F. Isett at iBio in 2021.